New pill shows promise for controlling stubborn high blood pressure
NCT ID NCT06381323
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 21 times
Summary
This study tested a new drug called finerenone in 55 adults with primary aldosteronism, a condition where a hormone imbalance causes high blood pressure. The goal was to see if finerenone can safely lower blood pressure over 12 weeks. Participants had high blood pressure despite treatment, and the study measured how much their blood pressure dropped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School
Nanjing, Jiangsu, 210008, China
Conditions
Explore the condition pages connected to this study.